Total Payments
$2,926
2024 Payments
$539.35
Companies
28
Transactions
140
Medicare Patients
5,400
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$2,553 (87.2%)
Education$373.88 (12.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,553 | 119 | 87.2% |
| Education | $373.88 | 21 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $453.42 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $286.13 | 12 | $0 (2024) |
| Travere Therapeutics, Inc. | $238.77 | 24 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $226.51 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $176.03 | 2 | $0 (2017) |
| Horizon Therapeutics plc | $157.65 | 3 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $150.84 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $142.69 | 8 | $0 (2024) |
| Amgen Inc. | $140.15 | 8 | $0 (2022) |
| OPKO Pharmaceuticals, LLC | $98.20 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $539.35 | 33 | Travere Therapeutics, Inc. ($105.46) |
| 2023 | $489.53 | 29 | Bayer Healthcare Pharmaceuticals Inc. ($94.87) |
| 2022 | $588.55 | 28 | Mallinckrodt Hospital Products Inc. ($150.84) |
| 2021 | $462.21 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($105.65) |
| 2020 | $125.54 | 4 | AstraZeneca Pharmaceuticals LP ($125.54) |
| 2019 | $191.38 | 6 | Horizon Therapeutics plc ($118.63) |
| 2018 | $152.71 | 11 | OPKO Pharmaceuticals, LLC ($80.21) |
| 2017 | $377.13 | 15 | E.R. Squibb & Sons, L.L.C. ($176.03) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Immunology | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.49 | General |
| 08/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $4.15 | General |
| 08/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 07/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/13/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.09 | General |
| 06/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 06/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 06/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 05/23/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEPHROLOGY | ||||||
| 02/27/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,046 | 1,728 | $434,860 | $172,152 |
| 2022 | 17 | 1,259 | 2,216 | $564,480 | $214,704 |
| 2021 | 14 | 1,377 | 2,592 | $796,545 | $302,834 |
| 2020 | 18 | 1,718 | 3,827 | $1.4M | $457,581 |
Total Patients
5,400
Total Services
10,363
Medicare Billing
$1.1M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 29 | 170 | $153,000 | $45,302 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 264 | $46,200 | $23,875 | 51.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 104 | 224 | $33,600 | $20,212 | 60.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 140 | 327 | $39,240 | $19,648 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 234 | 309 | $33,990 | $19,278 | 56.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 105 | $36,750 | $13,734 | 37.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 31 | $18,600 | $6,862 | 36.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 68 | 71 | $24,495 | $5,082 | 20.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 28 | $11,900 | $4,575 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $10,175 | $4,363 | 42.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 40 | 76 | $15,960 | $4,100 | 25.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $5,040 | $2,379 | 47.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $3,640 | $1,967 | 54.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 19 | $1,520 | $709.75 | 46.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 30 | $750.00 | $66.00 | 8.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 33 | 230 | $207,000 | $61,717 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 364 | $63,700 | $30,894 | 48.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 181 | 450 | $54,000 | $24,358 | 45.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 115 | 257 | $38,550 | $19,904 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 230 | 323 | $35,530 | $19,574 | 55.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 121 | 127 | $44,450 | $19,039 | 42.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 18 | 35 | $21,000 | $7,928 | 37.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 65 | 128 | $26,880 | $7,112 | 26.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 78 | 82 | $28,290 | $6,448 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $11,850 | $4,692 | 39.6% |
About Dr. Deep Adhikari, M.D
Dr. Deep Adhikari, M.D is a Nephrology healthcare provider based in Warner Robins, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1487821989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deep Adhikari, M.D has received a total of $2,926 in payments from pharmaceutical and medical device companies, with $539.35 received in 2024. These payments were reported across 140 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,553).
As a Medicare-enrolled provider, Adhikari has provided services to 5,400 Medicare beneficiaries, totaling 10,363 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine
- Location Warner Robins, GA
- Active Since 05/13/2008
- Last Updated 03/25/2015
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1487821989
Products in Payments
- Kerendia (Drug) $286.13
- LUPKYNIS (Drug) $226.51
- LOKELMA (Drug) $216.64
- ELIQUIS (Drug) $176.03
- KRYSTEXXA (Biological) $157.65
- ACTHAR (Biological) $150.84
- BENLYSTA (Biological) $142.69
- FARXIGA (Drug) $136.79
- Veltassa (Drug) $114.34
- BRILINTA (Drug) $99.99
- FreeStyle Libre 2 (Device) $87.39
- Rayaldee (Drug) $84.45
- IBSRELA (Drug) $69.60
- JYNARQUE (Drug) $68.65
- Velphoro (Drug) $61.39
- Tavneos (Drug) $59.14
- JARDIANCE (Drug) $50.27
- Fabhalta (Drug) $49.57
- Crysvita (Drug) $43.02
- Parsabiv (Drug) $41.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.